Tyrosine Kinase
<p>Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports</p>
... On the basis of data collected by the National Cancer Institute (NCI) in 2018, lung cancer remains the second most diagnosed cancer and the foremost cause of cancer- related death in both women and men. 1 Lung cancer ...
5
Molecular interactions of bruton's tyrosine kinase
... the BCR/TCR (or the presence of an oncogenic form of Abl) (Smit et al, 1996, Ribon et al, 1996). Thus it is possible that c-Cbl could link tyrosine kinase m ediated signals to a num ber of small GTPases and ...
198
Receptor tyrosine kinase signaling pathways: a review
... receptor tyrosine kinase pathway, focussing on their common alterations in human cancers and their clinical implications and ...receptor tyrosine signalling ...
7
TYROSINE KINASE AS TARGET FOR CANCER TREATMENT
... ABSTRACT: Cancer is a complex disease occurring as a result of a progressive accumulation of genetic aberrations and epigenetic changes that enable escape from normal cellular and environmental control. Cancer is treated ...
15
Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
... The close of the millenium is marked by unprecedented advances in our understanding of the mechanisms that underlie carcinogenesis. Each procarcinogenic pathway presents pharmacologists with an array of therapeutic ...
8
Prognostic value of spleen tyrosine kinase in human solid tumors
... “spleen tyrosine kinase”, “SYK”, or “P72-Syk”; “cancer”, “tumor”, “carcinoma”, or “neoplasms”; or “prognostic”, “prognosis”, “survival”, “mortality”, “recurrence”, or ...
8
Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors
... first tyrosine kinase inhibitor (TKI) approved by the Food and Drug Administration in 2001 is currently the first-line therapy for Ph + ...BCR-ABL kinase domain point mutation is the most com- mon ...
8
Second-generation inhibitors of Bruton tyrosine kinase
... cytoplasmic tyrosine kinase in the Tec family ...carboxyl kinase domain (Fig. 1). This tyrosine kinase lies downstream of the B cell antigen receptor (BCR) ...
7
Receptor tyrosine kinase targeting in multicellular spheroids
... Receptor tyrosine kinase (RTK) expression has been reported to be expressed differently in cells when grown 2D and 3D. For example, levels of RTKs VEGFR-1, VEGFR-2, TIE-1, and TIE-2 were found to be ...
8
Diversity of Receptor Tyrosine Kinase Signaling Mechanisms
... the kinase domain to inhibit its ...(FMS-like tyrosine kinase 3, a VEGF receptor), crystal structures suggest that the iJM region projects into the cleft between the N- and C-lobes, also contacting ...
177
Tyrosine kinase signalling in breast cancer: Tyrosine kinase mediated signal transduction in transgenic mouse models of human breast cancer
... The ability of growth factors and their cognate receptors to induce mammary epithelial proliferation and differentiation is dependent on their ability to activate a number of specific signal transduction pathways. ...
6
Functions of the Lyn tyrosine kinase in health and disease
... Src kinase (Csk) creating a binding site for its own SH2 ...and kinase domains (hinge region), helping generate a stabilized in- active kinase ...C-terminal tyrosine (Y508) by phosphatases ...
11
Role of C-Kit Receptor Tyrosine Kinase on INS-1 Cell VEGF-A Expression in Vitro
... most kinase activity, while VEGFR-1 serves primarily as a negative regulator due to a repressor sequence in the VEGFR-1 juxtamembrane ...identified tyrosine residues (Y949, Y994, Y1052, Y1057, Y1173, Y1212) ...
132
Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family.
... serine kinase (45, 49), although further characterization of the Nef-associated kinase has remained ...Nef-associated kinase activity in T ...the kinase activity is inhibited by staurosporine ...
5
Barrier effects of hyperosmolar signaling in microvascular endothelium of rat lung
... In this study, we tested the mechanisms of hyperosmolar barrier regulation in our single vessel model of lung transcapil- lary liquid exchange (7). Using the split-drop technique, this model allows assessment of ...
9
Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer
... The epidermal growth factor receptor (EGFR) tyrosine kinase family consists of four members: EGFR, ERBB2, ERBB3, and ERBB4. These receptors are activated when a ligand binds to their extracellular ligand ...
12
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation
... the tyrosine kinase inhibitor lavendustin A, the phosphatidylinositol3-kinase (PI3-kinase) inhibitor wortmannin, and mTOR/p70s6 kinase inhibitor rapamycin abolished ...p70s6 ...
9
Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells
... receptor tyrosine kinase-dependent signaling, STAT3 activation is increased by binding to certain STAT3 docking sites on EGFR c-terminal domains ...Janus Kinase (JAK) family proteins, which is ...
9
Activation of mesangial cells by the phosphatase inhibitor vanadate Potential implications for diabetic nephropathy
... a tyrosine phosphatase inhibitor, it may result in undesirable activation of target ...total tyrosine phosphatase activity and stimulated tyrosine phosphorylation of a set of cellular ...
10
Series Introduction: Invasive growth: from development to metastasis
... The extracellular region of the PRGF receptors con- tains the so-called sema domain, a conserved sequence encompassing about 500 amino acids. The sema domain was originally found in the extracellular domains of two ...
7